Why the study?
Elderly patients taking antithrombotics face risks of ischemic events or massive bleeding perioperatively, prompting investigation into the effects of long-term antithrombotic therapies on morbidity and mortality after hip fracture surgery.
Does long-term antithrombotic therapy affect perioperative morbidity and mortality in elderly patients undergoing hip fracture surgery?
Does long-term antithrombotic therapy affect perioperative morbidity and mortality in elderly patients undergoing hip fracture surgery?
Long-term dual antiplatelet therapy is associated with increased 30-day mortality in elderly patients undergoing hip fracture surgery, though major bleeding rates did not differ significantly among antithrombotic groups.
Antithrombotic regimens in elderly surgical patients need individualized perioperative planning; leaves open optimal balancing of ischemic versus bleeding risks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ceran et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: